GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aethlon Medical AEMD · USD

Health Care · US listing · 🇺🇸 United States

Compare

5.49

+0.37%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Aethlon Medical

From its filings with the US Securities and Exchange Commission

SEC filings

Aethlon Medical is based in San Diego, California and is incorporated in Nevada. Its shares trade on Nasdaq under the ticker AEMD. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 March 2024, it reported revenue of $0.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
9 Mar 1994
Employees
9
Head office
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA, 92121
Incorporated in
NV
Classification
Surgical & Medical Instruments & Apparatus
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Edward BroennimanIndependent Chairman of the Board$147,500
  • Mr. James FrakesChief Executive Officer, Chief Financial Officer, Director, since 2008$416,449
  • Mr. Steven LarosaChief Medical Officer$430,000
  • Mr. Nicolas GikakisIndependent Director$112,500
  • Ms. Angela RossettiIndependent Director$113,000
  • Dr. Chetan ShahIndependent Director$113,750
  • Ms. Susan NoonanManaging Partner, Investor Relations, since 2021

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Aethlon Medical Inc. operates in the Health Care sector with a focus on therapeutic technology.
  • The company's lead product, the Aethlon Hemopurifier, targets circulating viruses and tumor-secreted exosomes.
  • Aethlon Medical Inc. has a subsidiary, Exosome Sciences, Inc., developing exosome-based diagnostic products.

Weaknesses

  • Aethlon Medical Inc. has only 9 employees, indicating a small operational scale.
  • The company's IPO occurred in March 1994, reflecting a long history but limited recent growth.
  • Aethlon Medical Inc. operates in only one country, the United States.

Opportunities

  • The Aethlon Hemopurifier's application in oncology for targeting circulating exosomes presents a market opportunity.
  • Exosome Sciences, Inc. is developing exosome-based product candidates for neurological disorders and cancer diagnosis.
  • The company's focus on global health and biodefense needs aligns with emerging market demands.

Threats

  • The company's small employee count of 9 may limit its ability to scale operations.
  • Aethlon Medical Inc. has only one country of operation, the United States, increasing vulnerability to local market changes.
  • The therapeutic technology sector faces intense competition from larger healthcare companies.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.